NV
Novartis Venture Fund
Venture CapitalActiveNovartis Venture Fund is a venture capital firm focused on companies that develop novel therapeutics and platforms.
209
Investments
6
Exits
$1.2B
AUM
2.9%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Novartis Venture Fund.
Investment Thesis & Strategy
Novartis Venture Fund invests in various stages of companies developing novel therapeutics and platforms. They focus on companies within the therapeutics sector.
Notable Exits
CompanyTypeYearValue / Acquirer
AMAG PharmaceuticalsAcquisition2020$1.4B
Selexys PharmaceuticalsAcquisition2016—
Radius HealthIPO2014—
SequellaAcquisition2013—
ArchemixAcquisition2011—
Addex TherapeuticsIPO2007—
Frequently Asked Questions
Novartis Venture Fund focuses on Series A, Series B, Series C+ stage investments.